Table 2.
Baseline patient demographics and tumor characteristics for propensity-matched cohorts
| Surgery (n=1002) | Bladder preservation (n=1002) | Standardized Difference | ||
|---|---|---|---|---|
| Age at Diagnosis (median) | 73.95 (9.58) | 74.81 (9.48) | 0.090 | |
| Facility Type | Community Cancer Program | 112 (11.18) | 133 (13.27) | 0.064 |
| Comprehensive Community Cancer Program | 547 (54.59) | 529 (52.79) | 0.036 | |
| Academic/Research Program | 173 (17.27) | 265 (26.45) | 0.224 | |
| Integrated Network Cancer Program | 169 (16.87) | 74 (7.39) | 0.294 | |
| Other specified types of cancer programs | 1 (0.1) | 1 (0.1) | 0.000 | |
| Charlson-Deyo Score | 0 | 668 (66.67) | 658 (65.67) | 0.021 |
| 1 | 244 (24.35) | 254 (25.35) | 0.023 | |
| 2 | 90 (8.98) | 90 (8.98) | 0.000 | |
| Primary site | Trigone of bladder | 51 (5.09) | 61 (6.09) | 0.043 |
| Dome of bladder | 44 (4.39) | 45 (4.49) | 0.005 | |
| Bladder wall | 320 (31.94) | 300 (29.94) | 0.043 | |
| Bladder neck and ureteric orifice | 44 (4.39) | 49 (4.89) | 0.024 | |
| Bladder NOS | 543 (54.19) | 547 (54.59) | 0.008 | |
| T-stage | 2 | 910 (90.82) | 886 (88.42) | 0.079 |
| 3 | 92 (9.18) | 116 (11.58) | 0.079 |